Physician

Michael John Fumo, M.D.

According to 2025 Medicare claims, Michael Fumo, M.D. (NPI: 1528196656) practices urology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is ROCKFORD UROLOGICAL ASSOCIATES, LTD. (NPI: 1194786558; TIN: 36-2736715) and primary practice location at 61107-5298. Fumo is affiliated with the Mercy Health Corporation (ACO ID: A2097) and OSF Healthcare System (ACO ID: A3289), participating under the MSSP model.

Fumo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 635 traditional Medicare patients, billed 19,456 HCPCS/CPT codes, and received $497,631 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,760 prescription claims across 461 beneficiaries totaling $1,564,458 in drug costs, led by Xtandi (Enzalutamide). DME data shows 134 claims. Open Payments data shows 64 records totaling $1,235. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $276,147 and ending at $497,631. Concurrently, Part D prescription costs have risen steadily, from $73,725 to $1,564,458. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,391 and ending at $1,634.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	631	5,895	$276,147
2016	694	9,099	$343,171
2017	756	7,650	$325,875
2018	690	4,793	$207,340
2019	702	6,661	$342,159
2020	695	10,358	$229,825
2021	779	13,450	$240,698
2022	746	13,037	$374,519
2023	708	16,183	$604,721
2024	635	19,456	$497,631

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	272	898	$73,725
2016	327	1,135	$103,239
2017	340	1,297	$159,492
2018	326	1,259	$462,445
2019	349	1,336	$333,578
2020	364	1,388	$540,320
2021	427	1,540	$607,674
2022	404	1,574	$841,433
2023	460	1,768	$1,003,512
2024	461	1,760	$1,564,458

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	31	$1,428
2016	N/R	118	$23,833
2017	12	187	$37,122
2018	N/R	188	$33,793
2019	11	170	$46,361
2020	N/R	133	$14,726
2021	11	140	$60,540
2022	11	114	$67,220
2023	12	135	$78,491
2024	26	134	$87,668

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	216	310	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	215	249	$58
84153	Psa (prostate specific antigen) measurement, total	261	369	$18
36415	Insertion of needle into vein for collection of blood sample	265	373	$9
81003	Automated urinalysis test	419	623	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	65	1,950	$861,308
Abiraterone Acetate	Abiraterone Acetate	112	3,362	$275,454
Myrbetriq	Mirabegron	100	6,014	$88,563
Orgovyx	Relugolix	12	360	$30,580
Gemtesa	Vibegron	20	1,170	$18,646

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	14	54	$67,285
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	12	49	$19,471
A4332	Lubricant, individual sterile packet, each	N	N/R	31	$913

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$1,235	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael John Fumo, M.D.?

Tedicare shows public-source Medicare data for Michael John Fumo, M.D. (NPI 1528196656), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael John Fumo, M.D. have ACO affiliation data?

Michael John Fumo, M.D. is shown with ACO affiliation data for Mercy Health Corporation (MSSP, ACO ID A2097) and OSF Healthcare System (MSSP, ACO ID A3289).

What billing organization is linked to Michael John Fumo, M.D.?

Michael John Fumo, M.D. is linked to ROCKFORD UROLOGICAL ASSOCIATES, LTD. (billing NPI 1194786558) in the available physician profile data.

Does Michael John Fumo, M.D. have Open Payments data?

Michael John Fumo, M.D. has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.